Self-Monitoring Blood Glucose Devices Market research and trends report | Abbott Laboratories, All Medicus, Arkray, B. Braun Melsungen AG, Bayer Healthcare, Bionime Corporation, Dexcom, F. Hoffmann-La Roche, Johnson & Johnson, LifeScan, Medtronic, Nipro D

Self-Monitoring Blood Glucose Devices Market was valued at USD 14.3 billion in 2017 and is expected to witness 5.1% CAGR from 2018 to 2024; according to a new research report by Global Market Insights.

High prevalence of obesity across the globe coupled with rising geriatric population base prone to suffer from diabetes will serve to be another positive impact rendering factor for industry growth. Technological advancements in self-monitoring blood glucose devices offering more reliable, accurate and user-friendly devices will augment demand for such devices.

Technological innovations in self-monitoring blood glucose devices leading to development of portable, user-friendly and high efficiency self-monitoring blood glucose devices will boost the market growth over the analysis period. For instance, in 2015, Dexcom launched Dexcom G4 Platinum, consisting of an in-built hypoglycemia safety alert, customizable alerts to monitor rise and fall above user-selected limits as well as water-resistant sensor with attached transmitter. It works with Dexcom share app that sends real-time glucose values to the cloud allowing caregivers to monitor blood glucose readings. Increasing adoption of such technologically advanced self-monitoring blood glucose devices for diabetes management will upsurge the self-monitoring blood glucose devices market size throughout the forecast period.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/2743

However, high maintenance cost of advanced blood glucose devices and their accessories may restrain the self-monitoring blood glucose devices market growth over the forecast period. Moreover, stringent regulations for manufacturing such blood glucose monitoring devices will impede the industry growth to certain extent.

Testing strips segment dominated the self-monitoring blood glucose devices market in 2017 with more than 79.5% revenue share and is estimated to witness robust growth during the analysis period. Testing strips are an essential component of blood glucose meters that are widely used in diabetes care and management. Geriatric population base, prone to diabetes, will further increase the demand for SMBG devices.

Hospitals segment accounted for the highest revenue of USD 6.9 billion in 2017 and is estimated to witness lucrative CAGR of 4.6% during the forecast period. Increasing prevalence of diabetes across the world coupled with availability of technologically advanced blood glucose monitoring devices will serve to be high impact rendering factor in the segmental growth. Adoption of continuous glucose monitors for accurate, timely and efficient glucose measurement for ICU patients will stimulate the segmental growth in the coming years.

U.S. self-monitoring blood glucose devices market dominated global SMBG devices market with 34.2% revenue share in 2017 and is expected to show lucrative growth during the forecast period. Increasing prevalence of diabetes, availability of advanced healthcare infrastructure coupled with high healthcare expenditure are the key drivers that will accelerate industry growth over the coming years. Moreover, growing prevalence of obesity leading cause of diabetes will positively impact business growth. According to CDC, around 35.7% young adults aged between 20–39 years, 42.8% adults aged between 40-59 years, and 41.0% older population aged 60 and above suffered from obesity in 2016. Aforementioned factors will surge the U.S. self-monitoring blood glucose devices industry growth over the coming years.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/2743

Germany self-monitoring blood glucose devices market accounted for USD 869.4 million in 2017 and is estimated to witness 4.5% CAGR growth over the analysis period. Growing geriatric population base in Germany, prone to diabetes will serve to be major positive impact rendering factor for market growth. According to the United Nations, the elderly population base aged 60 years and above was around 22.9 million in 2017 and is expected to reach 29.8 million by 2050. Rising disposable income, increasing awareness among people regarding diabetes care and management as well as developments in healthcare facilities will foster SMBG devices industry growth in the coming years.

Some of the notable players operating in self-monitoring blood glucose devices market are Abbott Laboratories, All Medicus, Arkray, B. Braun Melsungen AG, Bayer Healthcare, Bionime Corporation, Dexcom, F. Hoffmann-La Roche, Johnson & Johnson, LifeScan, Medtronic, Nipro Diagnostics, Nova Biomedical, Sinocare and Trividia Health. Industry players primarily focus on strategic collaborations, acquisitions, mergers as well as innovative product launch to strengthen product portfolio and capture high revenue share. For instance, in August 2016, F. Hoffman-La Roche launched Accu-Chek Active blood glucose meter, to enable simple and accurate testing as well as ensure safe and reliable test results.

Self-Monitoring Blood Glucose Devices Market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2013 to 2024, for the following segments:

Self-Monitoring Blood Glucose Devices Market by Product
o Self-monitoring blood glucose meters
o Continuous glucose monitors
o Testing strips
o Lancets

Self-Monitoring Blood Glucose Devices Market by End-User
o Hospitals
o Home settings
o Diagnostic centers and clinics

Report Content

Chapter 1. Methodology
1.1. Methodology
1.2. Market definition
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary

Chapter 2. Executive Summary
2.1. Self-monitoring blood glucose devices industry 360º synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Product trends
2.1.3. End-user trends
2.1.4. Regional trends

Chapter 3. Self-Monitoring Blood Glucose Devices Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 – 2024 (USD Billion)
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Rising prevalence of diabetes worldwide
3.3.1.2. Technological advancements in developed countries
3.3.1.3. Government initiatives for increasing awareness among people
3.3.2. Industry pitfalls & challenges
3.3.2.1. High cost of advanced devices and accessories in developing economies
3.3.2.2. Lack of reimbursement and stringent regulations for SMBG devices
3.4. Growth potential analysis
3.4.1. By product
3.4.2. By end-user
3.5. Regulatory landscape
3.6. Porter’s analysis
3.7. Company landscape, 2017
3.7.1. Strategy dashboard
3.8. PESTEL analysis

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

This release was published on openPR.